DOMA intends to nominate three director candidates at Pacira annual meeting

Group 1 - DOMA Perpetual Capital Management owns approximately 6.83% of the outstanding shares of Pacira BioSciences (PCRX) and intends to nominate three independent director candidates at the Company's 2026 annual meeting of stockholders [1] - DOMA asserts that the Company's Board of Directors should pursue an immediate sale of the Company [1] - DOMA criticizes the current level of Executive Compensation and General Spending as exorbitant and unmerited, questioning the Board's fiduciary oversight [1]